Pharmaceutical Executive May 28, 2024
Mike Hollan

Slack, CEO and chairman for Start Center for Cancer Research, discusses the complications that patients have getting enrolled in clinical trials.

Clinical trials can offer patients who have run out of options with another chance at treatment. Unfortunately, actually getting enrolled in clinical trials is a much more complicated process than many people realize. Nick Slack, chairman and CEO of Start Center for Cancer Research, spoke with Pharmaceutical Executive about how his company works to make this easier on patients.

Pharmaceutical Executive: How did you get involved in this work?
Nick Slack: My background is nearly 20 years in the clinical research space, largely working for companies that have supported the process of clinical research, trying to make it function better...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Interview / Q&A, Patient / Consumer, Trends
FDA approves clinical trials for pig organ transplants
Supply chains and AI take precedence at European clinical trial meeting
Clinical trial: New drug combination reduces anemia in rare blood disorder
Transforming Clinical Trials with Alexander Saint-Amand
The New Product Development Landscape: Navigating the Challenges

Share This Article